National Health Investors (NHI) Shares Outstanding (Weighted Average) (2009 - 2026)

National Health Investors has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $48.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 5.69% year-over-year to $48.3 million; the trailing twelve-month figure through Mar 2026 stood at $48.3 million (up 5.69% YoY), and the FY2025 full-year result was $46.9 million, up 6.91% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $48.3 million, up from $46.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $48.3 million in Q1 2026, with the low at $43.4 million in Q1 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $44.9 million across 5 years, with a median of $44.3 million in 2022.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) decreased 5.37% — and 2025, when it grew 9.1%.
• National Health Investors' Shares Outstanding (Weighted Average) stood at $44.8 million in 2022, then retreated by 3.1% to $43.4 million in 2023, then rose by 1.05% to $43.8 million in 2024, then advanced by 6.91% to $46.9 million in 2025, then gained by 3.09% to $48.3 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $48.3 million (Q1 2026), $46.9 million (Q4 2025), and $47.4 million (Q3 2025), per Business Quant data.